Table of Content

1 Market Overview of Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform
1.1 Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Overview
1.1.1 Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Product Scope
1.1.2 Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Status and Outlook
1.2 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Overview by Region 2018 VS 2022 VS 2034
1.3 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Region (2018-2034)
1.4 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Historic Market Size by Region (2018-2024)
1.5 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size (2018-2034)
1.6.1 North America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size (2018-2034)
1.6.2 Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size (2018-2034)
1.6.3 Asia-Pacific Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size (2018-2034)
1.6.4 Latin America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size (2018-2034)
1.6.5 Middle East & Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size (2018-2034)
2 Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market by Type
2.1 Introduction
2.1.1 PQR-514
2.1.2 KA-2237
2.1.3 GSK-2636771
2.1.4 BAY-1082439
2.1.5 Others
2.2 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Type: 2018 VS 2022 VS 2034
2.2.1 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Historic Market Size by Type (2018-2024)
2.2.2 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue Breakdown by Type (2018-2034)
2.3.2 Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue Breakdown by Type (2018-2034)
2.3.3 Asia-Pacific Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue Breakdown by Type (2018-2034)
2.3.4 Latin America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue Breakdown by Type (2018-2034)
2.3.5 Middle East and Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue Breakdown by Type (2018-2034)
3 Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Overview by Application
3.1 Introduction
3.1.1 Gastric Cancer
3.1.2 Metastatic Colorectal Cancer
3.1.3 Myelofibrosis
3.1.4 Renal Cell Carcinoma
3.1.5 Others
3.2 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Application: 2018 VS 2022 VS 2034
3.2.1 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Historic Market Size by Application (2018-2024)
3.2.2 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue Breakdown by Application (2018-2034)
3.3.2 Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue Breakdown by Application (2018-2034)
3.3.3 Asia-Pacific Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue Breakdown by Application (2018-2034)
3.3.4 Latin America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue Breakdown by Application (2018-2034)
3.3.5 Middle East and Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue Breakdown by Application (2018-2034)
4 Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Competition Analysis by Players
4.1 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform as of 2022)
4.3 Date of Key Players Enter into Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market
4.4 Global Top Players Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Headquarters and Area Served
4.5 Key Players Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Product Solution and Service
4.6 Competitive Status
4.6.1 Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 AstraZeneca Plc
5.1.1 AstraZeneca Plc Profile
5.1.2 AstraZeneca Plc Main Business
5.1.3 AstraZeneca Plc Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Products, Services and Solutions
5.1.4 AstraZeneca Plc Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue (US$ Million) & (2018-2024)
5.1.5 AstraZeneca Plc Recent Developments
5.2 Bayer AG
5.2.1 Bayer AG Profile
5.2.2 Bayer AG Main Business
5.2.3 Bayer AG Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Products, Services and Solutions
5.2.4 Bayer AG Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue (US$ Million) & (2018-2024)
5.2.5 Bayer AG Recent Developments
5.3 Curis Inc
5.3.1 Curis Inc Profile
5.3.2 Curis Inc Main Business
5.3.3 Curis Inc Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Products, Services and Solutions
5.3.4 Curis Inc Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue (US$ Million) & (2018-2024)
5.3.5 GlaxoSmithKline Plc Recent Developments
5.4 GlaxoSmithKline Plc
5.4.1 GlaxoSmithKline Plc Profile
5.4.2 GlaxoSmithKline Plc Main Business
5.4.3 GlaxoSmithKline Plc Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Products, Services and Solutions
5.4.4 GlaxoSmithKline Plc Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue (US$ Million) & (2018-2024)
5.4.5 GlaxoSmithKline Plc Recent Developments
5.5 Karus Therapeutics Ltd
5.5.1 Karus Therapeutics Ltd Profile
5.5.2 Karus Therapeutics Ltd Main Business
5.5.3 Karus Therapeutics Ltd Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Products, Services and Solutions
5.5.4 Karus Therapeutics Ltd Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue (US$ Million) & (2018-2024)
5.5.5 Karus Therapeutics Ltd Recent Developments
5.6 Novartis AG
5.6.1 Novartis AG Profile
5.6.2 Novartis AG Main Business
5.6.3 Novartis AG Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Products, Services and Solutions
5.6.4 Novartis AG Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue (US$ Million) & (2018-2024)
5.6.5 Novartis AG Recent Developments
5.7 PIQUR Therapeutics AG
5.7.1 PIQUR Therapeutics AG Profile
5.7.2 PIQUR Therapeutics AG Main Business
5.7.3 PIQUR Therapeutics AG Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Products, Services and Solutions
5.7.4 PIQUR Therapeutics AG Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue (US$ Million) & (2018-2024)
5.7.5 PIQUR Therapeutics AG Recent Developments
6 North America
6.1 North America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Country (2018-2034)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Country (2018-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Region (2018-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Country (2018-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Country (2018-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Dynamics
11.1 Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Industry Trends
11.2 Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Drivers
11.3 Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Challenges
11.4 Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2034
Table 2. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Share by Region (2018-2024)
Table 4. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size (US$ Million) by Type: 2018 VS 2022 VS 2034
Table 7. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue Market Share by Type (2018-2024)
Table 9. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue Market Share by Type (2024-2034)
Table 11. North America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size (US$ Million) by Application: 2018 VS 2022 VS 2034
Table 22. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue Market Share by Application (2018-2024)
Table 24. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue Market Share by Application (2024-2034)
Table 26. North America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue (US$ Million) by Players (2018-2024)
Table 37. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform as of 2022)
Table 39. Date of Key Players Enter into Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market
Table 40. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Key Players Headquarters and Area Served
Table 41. Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Product Solution and Service
Table 42. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. AstraZeneca Plc Basic Information List
Table 45. AstraZeneca Plc Description and Business Overview
Table 46. AstraZeneca Plc Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Products, Services and Solutions
Table 47. Revenue (US$ Million) in Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Business of AstraZeneca Plc (2018-2024)
Table 48. AstraZeneca Plc Recent Developments
Table 49. Bayer AG Basic Information List
Table 50. Bayer AG Description and Business Overview
Table 51. Bayer AG Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Products, Services and Solutions
Table 52. Revenue (US$ Million) in Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Business of Bayer AG (2018-2024)
Table 53. Bayer AG Recent Developments
Table 54. Curis Inc Basic Information List
Table 55. Curis Inc Description and Business Overview
Table 56. Curis Inc Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Products, Services and Solutions
Table 57. Revenue (US$ Million) in Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Business of Curis Inc (2018-2024)
Table 58. Curis Inc Recent Developments
Table 59. GlaxoSmithKline Plc Basic Information List
Table 60. GlaxoSmithKline Plc Description and Business Overview
Table 61. GlaxoSmithKline Plc Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Products, Services and Solutions
Table 62. Revenue (US$ Million) in Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Business of GlaxoSmithKline Plc (2018-2024)
Table 63. GlaxoSmithKline Plc Recent Developments
Table 64. Karus Therapeutics Ltd Basic Information List
Table 65. Karus Therapeutics Ltd Description and Business Overview
Table 66. Karus Therapeutics Ltd Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Products, Services and Solutions
Table 67. Revenue (US$ Million) in Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Business of Karus Therapeutics Ltd (2018-2024)
Table 68. Karus Therapeutics Ltd Recent Developments
Table 69. Novartis AG Basic Information List
Table 70. Novartis AG Description and Business Overview
Table 71. Novartis AG Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Products, Services and Solutions
Table 72. Revenue (US$ Million) in Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Business of Novartis AG (2018-2024)
Table 73. Novartis AG Recent Developments
Table 74. PIQUR Therapeutics AG Basic Information List
Table 75. PIQUR Therapeutics AG Description and Business Overview
Table 76. PIQUR Therapeutics AG Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Products, Services and Solutions
Table 77. Revenue (US$ Million) in Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Business of PIQUR Therapeutics AG (2018-2024)
Table 78. PIQUR Therapeutics AG Recent Developments
Table 79. North America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Country (2018-2024) & (US$ Million)
Table 80. North America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Country (2024-2034) & (US$ Million)
Table 81. Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Country (2018-2024) & (US$ Million)
Table 82. Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Country (2024-2034) & (US$ Million)
Table 83. Asia-Pacific Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 84. Asia-Pacific Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Region (2018-2024) & (US$ Million)
Table 85. Asia-Pacific Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Region (2024-2034) & (US$ Million)
Table 86. Asia-Pacific Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Share by Region (2018-2024)
Table 87. Asia-Pacific Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Share by Region (2024-2034)
Table 88. Latin America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 89. Latin America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Country (2018-2024) & (US$ Million)
Table 90. Latin America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Country (2024-2034) & (US$ Million)
Table 91. Middle East & Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 92. Middle East & Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Country (2018-2024) & (US$ Million)
Table 93. Middle East & Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Country (2024-2034) & (US$ Million)
Table 94. Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Trends
Table 95. Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Drivers
Table 96. Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Challenges
Table 97. Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Restraints
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Year-over-Year 2018-2034 & (US$ Million)
Figure 2. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size (US$ Million), 2018 VS 2022 VS 2034
Figure 3. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Share by Regions: 2022 VS 2034
Figure 4. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 6. Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 7. Asia-Pacific Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 8. Latin America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 9. Middle East & Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 10. Product Picture of PQR-514
Figure 11. Global PQR-514 Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 12. Product Picture of KA-2237
Figure 13. Global KA-2237 Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 14. Product Picture of GSK-2636771
Figure 15. Global GSK-2636771 Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 16. Product Picture of BAY-1082439
Figure 17. Global BAY-1082439 Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 18. Product Picture of Others
Figure 19. Global Others Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 20. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Share by Type: 2022 & 2034
Figure 21. North America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue Market Share by Type (2018-2034)
Figure 22. Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue Market Share by Type (2018-2034)
Figure 23. Asia-Pacific Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue Market Share by Type (2018-2034)
Figure 24. Latin America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue Market Share by Type (2018-2034)
Figure 25. Middle East and Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue Market Share by Type (2018-2034)
Figure 26. Gastric Cancer Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 27. Metastatic Colorectal Cancer Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 28. Myelofibrosis Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 29. Renal Cell Carcinoma Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 30. Others Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 31. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Share by Application: 2022 & 2034
Figure 32. North America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue Market Share by Application (2018-2034)
Figure 33. Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue Market Share by Application (2018-2034)
Figure 34. Asia-Pacific Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue Market Share by Application (2018-2034)
Figure 35. Latin America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue Market Share by Application (2018-2034)
Figure 36. Middle East and Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue Market Share by Application (2018-2034)
Figure 37. Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 38. Global Top 5 and Top 10 Players Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Share in 2022
Figure 39. North America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Share by Country (2018-2034)
Figure 40. U.S. Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size (2018-2034) & (US$ Million)
Figure 41. Canada Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size (2018-2034) & (US$ Million)
Figure 42. Germany Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size (2018-2034) & (US$ Million)
Figure 43. France Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size (2018-2034) & (US$ Million)
Figure 44. U.K. Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size (2018-2034) & (US$ Million)
Figure 45. Italy Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size (2018-2034) & (US$ Million)
Figure 46. Russia Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size (2018-2034) & (US$ Million)
Figure 47. Nordic Countries Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size (2018-2034) & (US$ Million)
Figure 48. Asia-Pacific Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Share by Region (2018-2034)
Figure 49. China Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size (2018-2034) & (US$ Million)
Figure 50. Japan Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size (2018-2034) & (US$ Million)
Figure 51. South Korea Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size (2018-2034) & (US$ Million)
Figure 52. Southeast Asia Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size (2018-2034) & (US$ Million)
Figure 53. India Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size (2018-2034) & (US$ Million)
Figure 54. Australia Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size (2018-2034) & (US$ Million)
Figure 55. Latin America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Share by Country (2018-2034)
Figure 56. Mexico Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size (2018-2034) & (US$ Million)
Figure 57. Brazil Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size (2018-2034) & (US$ Million)
Figure 58. Middle East & Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Share by Country (2018-2034)
Figure 59. Turkey Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size (2018-2034) & (US$ Million)
Figure 60. Saudi Arabia Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size (2018-2034) & (US$ Million)
Figure 61. UAE Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size (2018-2034) & (US$ Million)
Figure 62. Bottom-up and Top-down Approaches for This Report